Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer
Pancreatic cancer consists of a heterogenous bulk of tumor cells and stroma cells which contribute to tumor progression by releasing angiogenic factors. Those factors can be detected as circulating serum factors. We performed a compartmentspecific analysis of tumor-derived and stroma-derived angioge...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
December 30, 2014
|
| In: |
OncoTarget
Year: 2014, Volume: 5, Issue: 24, Pages: 12978-12989 |
| ISSN: | 1949-2553 |
| DOI: | 10.18632/oncotarget.2651 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.18632/oncotarget.2651 Verlag, lizenzpflichtig, Volltext: https://www.oncotarget.com/article/2651/text/ |
| Author Notes: | Christoph Kahlert, Maria Fiala, Gabriel Musso, Niels Halama, Sophia Keim, Massimiliano Mazzone, Felix Lasitschka, Mathieu Pecqueux, Fee Klupp, Thomas Schmidt, Nuh Rahbari, Sebastian Schölch, Christian Pilarsky, Alexis Ulrich, Martin Schneider, Juergen Weitz, Moritz Koch |
| Summary: | Pancreatic cancer consists of a heterogenous bulk of tumor cells and stroma cells which contribute to tumor progression by releasing angiogenic factors. Those factors can be detected as circulating serum factors. We performed a compartmentspecific analysis of tumor-derived and stroma-derived angiogenic factors to identify biomarkers and molecular targets for the treatment of pancreatic cancer. |
|---|---|
| Item Description: | Gesehen am 16.10.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1949-2553 |
| DOI: | 10.18632/oncotarget.2651 |